BIS

ProShares - UltraShort Nasdaq Biotechnology

Financial ServicesAsset Management - LeveragedUSUSDPeers →via fmp_bulk

$16.86

LiveJun 11, 2026

Market cap

$2.3M

52w range

15.90 – 36.80

P / E

—

EPS

—

Volume

3.2K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on ProShares - UltraShort Nasdaq Biotechnology’s valuation

○

Insider buys and sells are sourced from SEC Form 4 filings, which cover US-listed issuers. We don't have Form 4 history for this name.

Transactions

0 buys · 0 sells

Bought

Open market

Sold

Open market

Net flow

+$0

Buys − sells

Insider	Role	Action	Shares	Price	Value	Trade date	Filing
No open-market insider activity in this window.

13F position evolution

No 13F history in institutional_holders for BIS.

Pro

Detailed insider buy/sell history is included with Pro.